The US Food and Drug Administration has approved the stimulant lisdexamfetamine to treat binge-eating disorder, the first product to be approved for the condition.
Researchers have discovered a mechanism that leads to the degradation of upper motor neurons, cells linked to the development of amyotrophic lateral sclerosis.
New research explored the option of treating ACE inhibitor–induced angioedema, a potentially life-threatening condition, with the bradykinin BB2-receptor antagonist icatibant.
In a recent study, researchers confirm that the dietary nitrates may be an alternative treatment to medication for patients who need to reduce their blood pressure.
This article reviews the pharmacological considerations for starting and continuing pain medication in older adults and the elderly and how to reduce the risks associated with aberrant drug use.
